VISA, Hetero-VISA and VRSA: The End of the Vancomycin Era?
dc.contributor.author | Conly, John M | |
dc.contributor.author | Johnston, B Lynn | |
dc.date.accessioned | 2018-09-27T12:24:22Z | |
dc.date.available | 2018-09-27T12:24:22Z | |
dc.date.issued | 2002-01-01 | |
dc.date.updated | 2018-09-27T12:24:21Z | |
dc.description.version | Peer Reviewed | |
dc.identifier.citation | John M Conly and B Lynn Johnston, “VISA, Hetero-VISA and VRSA: The End of the Vancomycin Era?,” Canadian Journal of Infectious Diseases, vol. 13, no. 5, pp. 282-284, 2002. doi:10.1155/2002/245109 | |
dc.identifier.doi | https://doi.org/10.1155/2002/245109 | |
dc.identifier.uri | http://hdl.handle.net/1880/108601 | |
dc.identifier.uri | https://doi.org/10.11575/PRISM/45222 | |
dc.language.rfc3066 | en | |
dc.rights.holder | Copyright © 2002 Hindawi Publishing Corporation. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. | |
dc.title | VISA, Hetero-VISA and VRSA: The End of the Vancomycin Era? | |
dc.type | Journal Article |